A comprehensive molecular profiling test designed to identify genetic alterations across 10 types of cancer. This test helps match patients with the most effective targeted therapies, immunotherapies, or clinical trials based on their tumor’s unique genetic makeup—supporting a personalized approach to cancer treatment and improving outcomes.
14 days upon receipt of sample in lab.